Biphasic effect of eserine and other acetylcholinesterase inhibitors on the nicotinic response to acetylcholine in cultured adrenal chromaffin cells.
D000109:Acetylcholine / Q000494:pharmacology; D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002093:Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D002800:Cholinesterase Inhibitors; D002838:Chromaffin System / Q000378:metabolism*; D009538:Nicotine / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology*; D011188:Potassium / Q000494:pharmacology; D013770:Tetraisopropylpyrophosphamide / Q000494:pharmacology; D014701:Veratridine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D002093:Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; D013770:Tetraisopropylpyrophosphamide; D009538:Nicotine; D014701:Veratridine; D010830:Physostigmine; D000109:Acetylcholine; D011188:Potassium; D009638:Norepinephrine